New Guidelines and FDA Communications Reshape Menopause Hormone Therapy Approach

Updated guidelines and new communications from the Food and Drug Administration (FDA) are influencing how healthcare providers view and prescribe menopause hormone therapy (MHT), previously known as hormone replacement therapy (HRT). This shift is seen as beneficial for many women experiencing menopausal symptoms, focusing on restoring hormones rather than simply replacing them.